Medilines Distributors Incorporated (MEDIC) Stock Price
Data as of: 22-Jan-2025 Wed 02:45 PM / Live Trading
₱0.305
-1.61%
(
$0.00520
in USD
)
Trading Data
Open Price
₱0.310
Day Low / High
₱0.295 - ₱0.320
52W Low / High
₱0.280 - ₱0.370
Trade Amount
₱81,200
Trade Volume
260,000
Valuation Metrics
Market Cap
₱837.71 Million
P/E Ratio
6.10
Earnings Per Share
₱0.0500
Book Value
₱0.840
Dividend Yield
-
The stock price of MEDIC today is ₱0.305, based on the most recent trading session. MEDIC share price decreased by 1.61% (see other notable decliners), with a trading volume of 260,000 shares.
Price Data by Timeframe
The table below provides a snapshot of the stock's performance over various timeframes.
Period | % Change | Average Price | Highest Price | Lowest Price | Average Volume | Average Trade |
---|---|---|---|---|---|---|
7 Days | -4.69% | ₱0.310 | ₱0.320 | ₱0.310 | 106,667 shares | ₱32,892 |
1 Month | 1.67% | ₱0.310 | ₱0.320 | ₱0.300 | 103,333 shares | ₱31,547 |
3 Months | -7.58% | ₱0.320 | ₱0.350 | ₱0.300 | 309,322 shares | ₱101,565 |
6 Months | 5.17% | ₱0.320 | ₱0.370 | ₱0.280 | 743,554 shares | ₱245,674 |
YTD | -3.17% | ₱0.310 | ₱0.320 | ₱0.310 | 111,333 shares | ₱33,990 |
1 Year | -1.61% | ₱0.310 | ₱0.370 | ₱0.280 | 552,582 shares | ₱177,282 |
Related Stocks:
MEDIC Stock Information
Sector
Services
Subsector
Other Services
Outstanding Shares
2,746,575,800
Share Type
Common
Listing Date
Dec 07, 2021
ISIN
PHY5921R1087
Board Lot
10000
Company Profile
Medilines Distributors, Incorporated (MEDIC) was incorporated and registered with the Securities and Exchange Commission on July 12, 2002. The Company's primary purpose is to establish, conduct and maintain business of trading and distribution of medical devices.MEDIC sources and maintains a portfolio of critical medical equipment from multinational medical device companies that cater to the specialized care segments namely, diagnostic imaging; dialysis; and cancer therapy. These categories, in turn, address some of the top causes of mortality among Filipinos – cardiovascular diseases, cancer, chronic obstructive pulmonary disease, diabetes, pneumonia, and tuberculosis.The Company's customers are primarily the Philippine government through the Department of Health and local government units, and private healthcare facilities such as hospitals, clinics and diagnostic centers.Source: SEC Form 17-A (2023)